Total Funding
59
52
Total FundingPost-IPO Equity raised
Growth Score
3 pts
Heat Score
27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81147
ImpediMed design and manufacture medical devices employing bioimpedance spectroscopy technologies.
- Richard Carreon: Managing Director & Chief Executive Officer
Catherine Kingsford: SVP Medical Affairs
About the Company
Impedimed is a designer and manufacturer of medical devices employing bioimpedance spectroscopy technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. They develop bioimpedance devices with medical applications for use in healthcare segments. They provide bioimpedance technology for
commercial applications including general health, weight management, bone content, and protein-calorie malnutrition.
